Tower Research Capital LLC (TRC) - NLS PHARMACEUTICS LTD ownership

Back to all holdings Add to watchlist

NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NLS PHARMACEUTICS LTD
ValueSharesWeighting
Q2 2023$110–1000.0%0.00%–
Q4 2022$0
-100.0%
100
-97.3%
0.00%–
Q1 2022$5,000
-96.6%
3,665
-90.0%
0.00%
-100.0%
Q1 2021$148,000–36,525–0.00%–
 Download
Other shareholders
NLS PHARMACEUTICS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
BVF INC/IL 5,747,126$3,970,6890.11%
Affinity Asset Advisors, LLC 200,455$140,3190.04%
J. Goldman & Co LP 254,601$178,2210.01%
BANK OF AMERICA CORP /DE/ 90$630.00%
WELLS FARGO & COMPANY/MN 56,549$39,5840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,362$9,9220.00%
Renaissance Technologies 21,100$150.00%
View complete list of NLS PHARMACEUTICS LTD shareholders